H. Hara

发表

Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging

P. Serruys, J. Wykrzykowska, J. Piek, 2020, Frontiers in Cardiovascular Medicine.

Current perspectives on bioresorbable scaffolds in coronary intervention and other fields

P. Serruys, Xinlei Wu, W. Wijns, 2021, Expert review of medical devices.

Intracoronary stenting of a coronary occlusion resulting from an aortic dissection.

Y. Ikari, T. Tamura, H. Hara, 1995, Catheterization and cardiovascular diagnosis.

Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.

P. Serruys, H. Thiele, A. Baumbach, 2020, American heart journal.

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

P. Serruys, H. Suryapranata, J. Wykrzykowska, 2020, Clinical Research in Cardiology.

Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, The American journal of cardiology.

Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials

P. Serruys, S. Garg, R. V. van Geuns, 2021, Circulation. Cardiovascular quality and outcomes.

Impact of the Clinical Syntax Score on 5-year clinical outcomes after sirolimus-eluting stents implantation

A. Nishi, K. Tanabe, K. Hara, 2013, Cardiovascular Intervention and Therapeutics.

Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.

J. Reiber, P. Serruys, A. Íñiguez, 2022, American heart journal.

Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study.

P. Serruys, E. Ribeiro, P. Lemos, 2020, JACC. Cardiovascular interventions.

Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Circulation. Cardiovascular interventions.

Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial.

P. Serruys, J. Wykrzykowska, P. Jüni, 2020, European heart journal. Cardiovascular pharmacotherapy.

Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Expert opinion on drug delivery.

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

P. Serruys, S. Garg, S. Windecker, 2020, Cardiovascular Diabetology.

Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Garg, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, International journal of cardiology.

Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study

D. van Klaveren, M. Mack, P. Serruys, 2021, Clinical Research in Cardiology.

The Impact of Coronary Physiology on Contemporary Clinical Decision Making.

Manesh R. Patel, D. Andreini, P. Serruys, 2020, JACC. Cardiovascular interventions.

Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond

P. Serruys, S. Garg, S. Windecker, 2021, European heart journal. Cardiovascular pharmacotherapy.

‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Windecker, 2021, European heart journal. Acute cardiovascular care.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial

P. Serruys, S. Garg, S. Windecker, 2020, Clinical Research in Cardiology.

Aortic regurgitation due to back-and-forth intimal flap movement detected by both multidetector computed tomography and transesophageal echocardiography.

K. Tanabe, K. Hara, Shuzou Tanimoto, 2013, Journal of cardiology cases.

Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.

M. Mack, P. Serruys, F. Mohr, 2021, Journal of the American College of Cardiology.

10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease.

M. Mack, P. Serruys, F. Mohr, 2021, Journal of the American College of Cardiology.

Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial).

M. Mack, P. Serruys, J. Wykrzykowska, 2021, The American journal of cardiology.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial.

D. van Klaveren, M. Mack, P. Serruys, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.

M. Mack, P. Serruys, F. Mohr, 2020, Journal of the American College of Cardiology.

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

P. Serruys, S. Garg, S. Windecker, 2020, Cardiovascular Diabetology.

Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.

D. van Klaveren, M. Mack, P. Serruys, 2020, Journal of the American College of Cardiology.

Mortality after multivessel revascularisation involving the proximal left anterior descending artery

M. Mack, P. Serruys, F. Mohr, 2022, Heart.

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

J. J. Piek, Deepak L. Bhatt, P. Serruys, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Reply: Composite endpoints in clinical trials - simplicity or perfection?

P. Serruys, Y. Onuma, H. Hara, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The "A, B, C" of multiple statistical methods for composite endpoints.

D. van Klaveren, P. Serruys, D. Capodanno, 2020, EuroIntervention.

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.

P. Serruys, J. Wykrzykowska, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions.

M. Mack, P. Serruys, F. Mohr, 2021, Journal of the American College of Cardiology.

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial.

P. Serruys, R. D. de Winter, S. Garg, 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Trade-Off Between Bleeding and Thrombotic Risk in Patients With Academic Research Consortium for High Bleeding Risk.

P. Serruys, H. Kawashima, M. Ono, 2021, JAMA cardiology.

10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.

M. Mack, P. Serruys, R. D. de Winter, 2021, JACC. Cardiovascular interventions.

Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.

M. Mack, P. Serruys, D. Holmes, 2021, International Journal of Cardiology.

Have We Overdefined Periprocedural Myocardial Infarction to the Point of Extinction?

P. Serruys, S. Garg, Y. Onuma, 2021, JACC. Cardiovascular interventions.

Signet ring-like appearance: specific feature of vulnerable plaques detected by 320-slice multidetector computed tomography.

K. Tanabe, K. Hara, J. Aoki, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Ten-year all-cause mortality following staged percutaneous revascularization in patients with complex coronary artery disease.

P. Serruys, R. D. de Winter, S. Garg, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Are We Unisex When Undergoing Left Main Revascularization?

P. Serruys, S. Garg, Y. Onuma, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Did the SYNTAX Score Pass the Test of Time?

P. Serruys, Y. Onuma, H. Hara, 2020, JACC. Cardiovascular interventions.

Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization

M. Mack, J. Spertus, P. Serruys, 2022, Circulation.

A Prospective Multicenter Validation Study for A Novel Angiography-derived Physiological Assessment Software: Rationale and Design of the Radiographic imaging Validation and EvALuation for Angio-iFR (ReVEAL iFR) study.

M. Grass, P. Serruys, J. Wykrzykowska, 2021, American heart journal.

Mid-term follow-up of coronary artery aneurysm after directional coronary atherectomy.

K. Kozuma, T. Tamura, H. Hara, 1999, Journal of cardiology.

Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective.

D. Andreini, P. Serruys, S. Garg, 2021, Journal of the American College of Cardiology.

External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial

P. Serruys, S. Windecker, M. Valgimigli, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

P. Serruys, T. Ismail, M. Nishino, 2022, Cardiovascular Intervention and Therapeutics.

Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.

P. Serruys, M. Flather, A. Diegeler, 2021, European heart journal.

Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events

V. Ribeiro, D. van Klaveren, P. Serruys, 2020, Circulation. Cardiovascular quality and outcomes.

The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, Atherosclerosis.

Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease

P. Serruys, V. Fuster, F. Burzotta, 2021, European heart journal.

Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease

P. Serruys, S. Garg, R. V. van Geuns, 2021, Clinical Research in Cardiology.

Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review.

Jeroen J. Bax, D. Andreini, J. Leipsic, 2021, Journal of the American College of Cardiology.

Regional variation in patients and outcomes in the GLOBAL LEADERS trial.

P. Serruys, S. Garg, S. Windecker, 2020, International journal of cardiology.

Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events

P. Serruys, H. Suryapranata, R. D. de Winter, 2020, Thrombosis and Haemostasis.

Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.

P. Serruys, S. Garg, R. Geuns, 2020, The Canadian journal of cardiology.

Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study.

P. Serruys, G. Nakazawa, Y. Ozaki, 2023, AsiaIntervention.

Incidence and predictors for late target lesion revascularization after sirolimus-eluting stent implantation.

K. Tanabe, K. Hara, K. Yahagi, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease

M. Mack, P. Serruys, F. Mohr, 2021, European heart journal.

Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization.

P. Serruys, F. Mohr, F. Burzotta, 2023, Clinical research in cardiology : official journal of the German Cardiac Society.

TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease

V. Fuster, P. Serruys, S. Garg, 2021, Journal of the American College of Cardiology.

Diagnostic concordance and discordance between angiography-based quantitative flow ratio and fractional flow reserve derived from computed tomography in complex coronary artery disease.

D. Andreini, J. Reiber, P. Serruys, 2022, Journal of cardiovascular computed tomography.

External Validation of the SYNTAX Score II 2020.

D. van Klaveren, E. Steyerberg, D. Kent, 2021, Journal of the American College of Cardiology.

A prospective multicenter randomized trial to assess the effectiveness of the magic touch sirolimus-coated balloon in small vessels: Rationale and design of the TRANSFORM I trial.

P. Serruys, J. Wykrzykowska, J. Piek, 2020, Cardiovascular revascularization medicine : including molecular interventions.

The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX.

P. Serruys, R. D. de Winter, R. V. van Geuns, 2020, Future Cardiology.

The state-of-the-art coronary stent with crystallized sirolimus: the MiStent technology and its clinical program.

P. Serruys, Xinlei Wu, J. Wykrzykowska, 2020, Future cardiology.

Impact of stent length and diameter on 10‐year mortality in the SYNTAXES trial

M. Mack, P. Serruys, F. Mohr, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[Ten-year follow-up of percutaneous transluminal coronary angioplasty].

T. Tamura, H. Hara, J. Ako, 1996, Journal of cardiology.

Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease

J. Spertus, P. Serruys, J. Wykrzykowska, 2022, European heart journal. Quality of care & clinical outcomes.

A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial.

J. Reiber, P. Serruys, A. Zaman, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI.

S. Garg, Shimpei Nakatani, K. Tanabe, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience

S. Achenbach, P. Serruys, J. Wykrzykowska, 2022, Reviews in cardiovascular medicine.